News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,873 Results
Type
Article (32287)
Company Profile (136)
Press Release (454450)
Section
Business (134585)
Career Advice (1165)
Deals (23665)
Drug Delivery (91)
Drug Development (45345)
Employer Resources (101)
FDA (11926)
Job Trends (11873)
News (222989)
Policy (24133)
Tag
Academia (2420)
Alliances (37540)
Alzheimer's disease (946)
Approvals (11946)
Artificial intelligence (156)
Bankruptcy (198)
Best Places to Work (10223)
Breast cancer (148)
Cancer (1024)
Cardiovascular disease (98)
Career advice (1004)
Cell therapy (191)
Clinical research (36730)
Collaboration (488)
Compensation (181)
COVID-19 (2329)
C-suite (100)
Data (1026)
Diabetes (141)
Diagnostics (5615)
Drug pricing (105)
Earnings (44870)
Employer resources (88)
Events (81852)
Executive appointments (416)
FDA (12570)
Funding (440)
Gene therapy (131)
GLP-1 (430)
Government (4354)
Healthcare (16960)
Infectious disease (2420)
Inflammatory bowel disease (85)
Interviews (175)
IPO (10332)
Job creations (2086)
Job search strategy (881)
Layoffs (205)
Legal (4917)
Lung cancer (140)
Manufacturing (191)
Medical device (10735)
Medtech (10738)
Mergers & acquisitions (13611)
Metabolic disorders (372)
Neuroscience (1195)
NextGen: Class of 2025 (5855)
Non-profit (4557)
Northern California (1346)
Obesity (217)
Opinion (133)
People (41857)
Phase I (11569)
Phase II (14957)
Phase III (12779)
Pipeline (464)
Policy (90)
Postmarket research (1739)
Preclinical (3992)
Radiopharmaceuticals (178)
Rare diseases (215)
Real estate (4595)
Regulatory (16126)
Research institute (2209)
Resumes & cover letters (147)
Southern California (1092)
Startups (2432)
United States (12694)
Vaccines (510)
Weight loss (137)
Date
Today (2)
Last 7 days (467)
Last 30 days (2112)
Last 365 days (25436)
2025 (2157)
2024 (25764)
2023 (29209)
2022 (39103)
2021 (43167)
2020 (43348)
2019 (39645)
2018 (29837)
2017 (22381)
2016 (23382)
2015 (26795)
2014 (20262)
2013 (16611)
2012 (17905)
2011 (18668)
2010 (16381)
Location
Africa (638)
Arizona (138)
Asia (27673)
Australia (4597)
California (2970)
Canada (1329)
China (296)
Colorado (158)
Connecticut (180)
Europe (60918)
Florida (478)
Georgia (137)
Illinois (363)
Indiana (232)
Japan (94)
Maryland (539)
Massachusetts (2334)
Michigan (133)
Minnesota (221)
New Jersey (1025)
New York (914)
North Carolina (670)
Northern California (1346)
Ohio (130)
Pennsylvania (803)
South America (894)
Southern California (1092)
Texas (412)
Utah (112)
Washington State (340)
486,873 Results for "national health service".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea
Antengene Corporation Limited announced that South Korea’s National Health Insurance Service has approved the reimbursement of XPOVIO® for the treatment of adult patients with relapsed or refractory multiple myeloma.
June 26, 2024
·
5 min read
BioMidwest
BrightSpring Health Services Specialty Pharmacy Onco360® Selected as National Pharmacy Partner for Voydeya®
BrightSpring Health Services announced that its company Onco360®, a leading independent oncology pharmacy, was selected as a national pharmacy partner by Alexion Pharmaceuticals for a first-in-class, oral, Factor D inhibitor, Voydeya® to treat patients with a rare, life-threatening disease of the blood called paroxysmal nocturnal hemoglobinuria who are experiencing extravascular hemolysis.
April 10, 2024
·
3 min read
Press Releases
Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
January 23, 2025
·
10 min read
Press Releases
IVOS Medical Receives Phase II SBIR Award from the National Institutes of Health for $1.9M
January 22, 2025
·
2 min read
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Press Releases
Enalare Therapeutics Receives Second Component of a National Institutes of Health (NIH) Grant Award to Fund the Next Human Study of ENA-001
January 30, 2025
·
4 min read
Press Releases
Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
September 5, 2024
·
5 min read
Press Releases
LifeLabs Named Canada’s Most Trusted Health Diagnostic Service Provider for Third Consecutive Year by BrandSpark Most Trusted Awards
January 21, 2025
·
2 min read
Press Releases
ScribeEMR to Highlight AI Scribing and Virtual Coding Advances at the National Association of Community Health Center’s Policy & Issues Forum (Booth 215)
January 30, 2025
·
1 min read
Press Releases
Parse Biosciences Welcomes Admera Health as Newest Member of Certified Service Provider Network
December 19, 2024
·
3 min read
1 of 48,688
Next
